IBERSOL SGPS SA (IBS.LS) Stock Fundamental Analysis
Europe - Euronext Lisbon - ELI:IBS - PTIBS0AM0008 - Common Stock
10.05 EUR
-0.1 (-0.99%)
Overall IBS gets a fundamental rating of 4 out of 10. We evaluated IBS against 56 industry peers in the Hotels, Restaurants & Leisure industry. IBS has only an average score on both its financial health and profitability. IBS is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
IBS had positive earnings in the past year.
IBS had a positive operating cash flow in the past year.
Of the past 5 years IBS 4 years were profitable.
In the past 5 years IBS always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of IBS (1.51%) is comparable to the rest of the industry.
The Return On Equity of IBS (3.42%) is better than 60.71% of its industry peers.
IBS has a Return On Invested Capital of 3.81%. This is comparable to the rest of the industry: IBS outperforms 50.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for IBS is significantly below the industry average of 11.27%.
The 3 year average ROIC (3.32%) for IBS is below the current ROIC(3.81%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.51% | ||
| ROE | 3.42% | ||
| ROIC | 3.81% |
ROA(3y)9.49%
ROA(5y)5.17%
ROE(3y)16.68%
ROE(5y)5.68%
ROIC(3y)3.32%
ROIC(5y)N/A
1.3 Margins
IBS has a Profit Margin of 2.07%. This is comparable to the rest of the industry: IBS outperforms 51.79% of its industry peers.
IBS's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 5.03%, IBS perfoms like the industry average, outperforming 51.79% of the companies in the same industry.
IBS's Operating Margin has declined in the last couple of years.
IBS has a Gross Margin (50.98%) which is in line with its industry peers.
In the last couple of years the Gross Margin of IBS has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.03% | ||
| PM (TTM) | 2.07% | ||
| GM | 50.98% |
OM growth 3Y-40.02%
OM growth 5Y-6.76%
PM growth 3Y-42.54%
PM growth 5Y-4.22%
GM growth 3Y-0.29%
GM growth 5Y-0.28%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so IBS is destroying value.
The number of shares outstanding for IBS has been reduced compared to 1 year ago.
IBS has more shares outstanding than it did 5 years ago.
The debt/assets ratio for IBS is higher compared to a year ago.
2.2 Solvency
IBS has an Altman-Z score of 2.01. This is not the best score and indicates that IBS is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.01, IBS is in the better half of the industry, outperforming 66.07% of the companies in the same industry.
The Debt to FCF ratio of IBS is 4.26, which is a neutral value as it means it would take IBS, 4.26 years of fcf income to pay off all of its debts.
IBS's Debt to FCF ratio of 4.26 is fine compared to the rest of the industry. IBS outperforms 71.43% of its industry peers.
IBS has a Debt/Equity ratio of 0.71. This is a neutral value indicating IBS is somewhat dependend on debt financing.
IBS has a better Debt to Equity ratio (0.71) than 73.21% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.71 | ||
| Debt/FCF | 4.26 | ||
| Altman-Z | 2.01 |
ROIC/WACC0.61
WACC6.21%
2.3 Liquidity
A Current Ratio of 0.96 indicates that IBS may have some problems paying its short term obligations.
The Current ratio of IBS (0.96) is better than 60.71% of its industry peers.
IBS has a Quick Ratio of 0.96. This is a bad value and indicates that IBS is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.87, IBS is in the better half of the industry, outperforming 60.71% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.96 | ||
| Quick Ratio | 0.87 |
3. Growth
3.1 Past
IBS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -30.51%.
IBS shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -8.23% yearly.
The Revenue has grown by 17.65% in the past year. This is quite good.
The Revenue has been decreasing by -0.46% on average over the past years.
EPS 1Y (TTM)-30.51%
EPS 3Y-29.2%
EPS 5Y-8.23%
EPS Q2Q%100%
Revenue 1Y (TTM)17.65%
Revenue growth 3Y32.48%
Revenue growth 5Y-0.46%
Sales Q2Q%18.09%
3.2 Future
The Earnings Per Share is expected to grow by 18.20% on average over the next years. This is quite good.
The Revenue is expected to grow by 6.77% on average over the next years.
EPS Next Y-16.54%
EPS Next 2Y15.36%
EPS Next 3Y20.34%
EPS Next 5Y18.2%
Revenue Next Year15.39%
Revenue Next 2Y9.99%
Revenue Next 3Y8.52%
Revenue Next 5Y6.77%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 38.65 indicates a quite expensive valuation of IBS.
IBS's Price/Earnings is on the same level as the industry average.
IBS's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 26.31.
A Price/Forward Earnings ratio of 23.55 indicates a rather expensive valuation of IBS.
The rest of the industry has a similar Price/Forward Earnings ratio as IBS.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.59, IBS is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 38.65 | ||
| Fwd PE | 23.55 |
4.2 Price Multiples
IBS's Price/Free Cash Flow ratio is rather cheap when compared to the industry. IBS is cheaper than 83.93% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 5.89 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
IBS's earnings are expected to grow with 20.34% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.36%
EPS Next 3Y20.34%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 6.76%, IBS is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 2.83, IBS pays a better dividend. On top of this IBS pays more dividend than 100.00% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.40, IBS pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.76% |
5.2 History
On average, the dividend of IBS grows each year by 48.65%, which is quite nice.
Dividend Growth(5Y)48.65%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
IBS pays out 268.99% of its income as dividend. This is not a sustainable payout ratio.
IBS's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP268.99%
EPS Next 2Y15.36%
EPS Next 3Y20.34%
ELI:IBS (11/28/2025, 7:00:00 PM)
10.05
-0.1 (-0.99%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)
Earnings (Next)
Inst Owners21.88%
Inst Owner ChangeN/A
Ins Owners0.03%
Ins Owner ChangeN/A
Market Cap417.18M
Revenue(TTM)511.65M
Net Income(TTM)10.61M
Analysts83.33
Price Target11.82 (17.61%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.76% |
Yearly Dividend0.49
Dividend Growth(5Y)48.65%
DP268.99%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)5.24%
Min Revenue beat(2)-0.81%
Max Revenue beat(2)11.28%
Revenue beat(4)3
Avg Revenue beat(4)8.29%
Min Revenue beat(4)-0.81%
Max Revenue beat(4)12.41%
Revenue beat(8)7
Avg Revenue beat(8)6.42%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 38.65 | ||
| Fwd PE | 23.55 | ||
| P/S | 0.82 | ||
| P/FCF | 5.89 | ||
| P/OCF | 3.58 | ||
| P/B | 1.34 | ||
| P/tB | 1.97 | ||
| EV/EBITDA | N/A |
EPS(TTM)0.26
EY2.59%
EPS(NY)0.43
Fwd EY4.25%
FCF(TTM)1.71
FCFY16.99%
OCF(TTM)2.81
OCFY27.95%
SpS12.33
BVpS7.47
TBVpS5.09
PEG (NY)N/A
PEG (5Y)N/A
Graham Number6.61
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.51% | ||
| ROE | 3.42% | ||
| ROCE | 4.85% | ||
| ROIC | 3.81% | ||
| ROICexc | 4.93% | ||
| ROICexgc | 6.48% | ||
| OM | 5.03% | ||
| PM (TTM) | 2.07% | ||
| GM | 50.98% | ||
| FCFM | 13.85% |
ROA(3y)9.49%
ROA(5y)5.17%
ROE(3y)16.68%
ROE(5y)5.68%
ROIC(3y)3.32%
ROIC(5y)N/A
ROICexc(3y)5.24%
ROICexc(5y)N/A
ROICexgc(3y)7.05%
ROICexgc(5y)N/A
ROCE(3y)4.21%
ROCE(5y)N/A
ROICexgc growth 3Y-24.94%
ROICexgc growth 5Y-3.32%
ROICexc growth 3Y-22.88%
ROICexc growth 5Y-3.24%
OM growth 3Y-40.02%
OM growth 5Y-6.76%
PM growth 3Y-42.54%
PM growth 5Y-4.22%
GM growth 3Y-0.29%
GM growth 5Y-0.28%
F-Score6
Asset Turnover0.73
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.71 | ||
| Debt/FCF | 4.26 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | 8.93% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | N/A | ||
| Profit Quality | 667.98% | ||
| Current Ratio | 0.96 | ||
| Quick Ratio | 0.87 | ||
| Altman-Z | 2.01 |
F-Score6
WACC6.21%
ROIC/WACC0.61
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)9.76%
Cap/Sales(5y)11.65%
Profit Quality(3y)200.89%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-30.51%
EPS 3Y-29.2%
EPS 5Y-8.23%
EPS Q2Q%100%
EPS Next Y-16.54%
EPS Next 2Y15.36%
EPS Next 3Y20.34%
EPS Next 5Y18.2%
Revenue 1Y (TTM)17.65%
Revenue growth 3Y32.48%
Revenue growth 5Y-0.46%
Sales Q2Q%18.09%
Revenue Next Year15.39%
Revenue Next 2Y9.99%
Revenue Next 3Y8.52%
Revenue Next 5Y6.77%
EBIT growth 1Y19.24%
EBIT growth 3Y-20.54%
EBIT growth 5Y-7.19%
EBIT Next Year434.69%
EBIT Next 3Y84.16%
EBIT Next 5Y57.33%
FCF growth 1Y26.38%
FCF growth 3Y-0.14%
FCF growth 5Y-9.32%
OCF growth 1Y23.94%
OCF growth 3Y1.82%
OCF growth 5Y-6.35%
IBERSOL SGPS SA / IBS.LS FAQ
What is the ChartMill fundamental rating of IBERSOL SGPS SA (IBS.LS) stock?
ChartMill assigns a fundamental rating of 4 / 10 to IBS.LS.
What is the valuation status for IBS stock?
ChartMill assigns a valuation rating of 3 / 10 to IBERSOL SGPS SA (IBS.LS). This can be considered as Overvalued.
Can you provide the profitability details for IBERSOL SGPS SA?
IBERSOL SGPS SA (IBS.LS) has a profitability rating of 4 / 10.
Can you provide the financial health for IBS stock?
The financial health rating of IBERSOL SGPS SA (IBS.LS) is 4 / 10.
What is the earnings growth outlook for IBERSOL SGPS SA?
The Earnings per Share (EPS) of IBERSOL SGPS SA (IBS.LS) is expected to decline by -16.54% in the next year.